Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and noc 18

quinoxalines has been researched along with noc 18 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Galle, J; Hatzelmann, A; Hübner, U; Schmidt, HH; Wagner, B; Wanner, C; Zabel, U1
Becherini, L; MacIntyre, I; Mancini, L; Martineti, V; Moradi-Bidhendi, N1
Campbell, C; Komai-Koma, M; Liew, FY; Niedbala, W; Thomson, D; Wei, XQ1
Altun, A; Bagcivan, I; Durmus, N; Gursoy, S; Ozdemir, E1

Other Studies

4 other study(ies) available for quinoxalines and noc 18

ArticleYear
Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    British journal of pharmacology, 1999, Volume: 127, Issue:1

    Topics: Animals; Aorta, Thoracic; Cyclic GMP; Enzyme Activation; Enzyme Inhibitors; Guanylate Cyclase; In Vitro Techniques; Indazoles; Isoenzymes; Kinetics; Muscle Contraction; Muscle Relaxation; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitroprusside; Nitroso Compounds; Oxadiazoles; Phosphoric Diester Hydrolases; Quinoxalines; Rabbits; Vasodilator Agents

1999
The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependent.
    Biochemical and biophysical research communications, 2000, Aug-02, Volume: 274, Issue:2

    Topics: Alkaline Phosphatase; Animals; Apoptosis; Cell Division; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Nitroso Compounds; Osteoblasts; Oxadiazoles; Quinoxalines; Rats; Rats, Wistar

2000
Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Dec-10, Volume: 99, Issue:25

    Topics: Animals; CD8-Positive T-Lymphocytes; Cells, Cultured; Cyclic GMP; Enzyme Activation; Enzyme Inhibitors; Female; Gene Expression Regulation; Guanylate Cyclase; Humans; Male; Mice; Mice, Inbred BALB C; Models, Immunological; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroso Compounds; Oxadiazoles; Polymerase Chain Reaction; Quinoxalines; Receptors, Interleukin; Receptors, Interleukin-12; Receptors, Interleukin-4; Signal Transduction; Th1 Cells; Th2 Cells

2002
Soluble guanylyl cyclase activators increase the expression of tolerance to morphine analgesic effect.
    Bratislavske lekarske listy, 2014, Volume: 115, Issue:6

    Topics: Analgesics, Opioid; Animals; Drug Tolerance; Enzyme Activators; Enzyme Inhibitors; Guanylate Cyclase; Male; Molsidomine; Morphine; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Photosensitizing Agents; Protoporphyrins; Quinoxalines; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Restriction Mapping; S-Nitroso-N-Acetylpenicillamine; Soluble Guanylyl Cyclase

2014